Michael D. Schreiber to Hypoxia
This is a "connection" page, showing publications Michael D. Schreiber has written about Hypoxia.
Connection Strength
0.328
-
Cardiopulmonary effects of nebulized sodium nitroprusside in term infants with hypoxic respiratory failure. J Pediatr. 2003 Nov; 143(5):640-3.
Score: 0.161
-
Leukotriene inhibition prevents and reverses hypoxic pulmonary vasoconstriction in newborn lambs. Pediatr Res. 1985 May; 19(5):437-41.
Score: 0.045
-
Direct comparison of the effects of nebulized nitroprusside versus inhaled nitric oxide on pulmonary and systemic hemodynamics during hypoxia-induced pulmonary hypertension in piglets. Crit Care Med. 2002 Nov; 30(11):2560-5.
Score: 0.038
-
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med. 1997 Feb 27; 336(9):605-10.
Score: 0.025
-
Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC Pediatr. 2013 Dec 17; 13:207.
Score: 0.020
-
Cromolyn sodium does not prevent hypoxia-induced pulmonary hypertension in newborn and young lambs. J Dev Physiol. 1988 Dec; 10(6):555-65.
Score: 0.014
-
The differential effects of leukotriene C4 and D4 on the pulmonary and systemic circulations in newborn lambs. Pediatr Res. 1987 Feb; 21(2):176-82.
Score: 0.013
-
Increased arterial pH, not decreased PaCO2, attenuates hypoxia-induced pulmonary vasoconstriction in newborn lambs. Pediatr Res. 1986 Feb; 20(2):113-7.
Score: 0.012